Evaluation of Sensititre YeastOne for antifungal susceptibility testing of <i>Candida (Candidozyma) auris</i>: misclassification of <i>FKS1</i> mutants and overestimation of caspofungin resistance in a global collection of isolates. [PDF]
Siopi M +11 more
europepmc +1 more source
<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]
Klamer KS +4 more
europepmc +1 more source
Predictors of <i>Candida auris</i> Infection in Previously Colonized Patients: A Retrospective Cohort Study from a Large Tertiary Reference Center. [PDF]
Ergün N +4 more
europepmc +1 more source
Therapeutic Challenges in Case of Trichophyton indotineae Dermatophytosis, Singapore, 2025. [PDF]
Foo TJ, Koh MCY, Chew KL, Juay L, Wu SJ.
europepmc +1 more source
Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in <i>Candida auris</i> (<i>Candidozyma auris</i>) Isolates. [PDF]
Turan D, Sarmis A, Adaleti R, Aksaray S.
europepmc +1 more source
A Calcineurin Inhibitor as an Enhancer of <i>Candida</i> Susceptibility to Anidulafungin. [PDF]
Rovira I +7 more
europepmc +1 more source
Six-month surveillance of <i>Candida parapsilosis</i> in Tyrol, Austria: high-risk ST11 lineage and early, heterogeneous fluconazole resistance. [PDF]
Steixner S +4 more
europepmc +1 more source
Antifungal susceptibility profiles of candidemia isolates on the east coast of Peninsular Malaysia and reliability of Etest compared to Sensititre YeastOne. [PDF]
Abdullah SNS, Tzar MN, Othman SN.
europepmc +1 more source
Clinical and Microbiological Characteristics of Sterile-Site Saccharomyces cerevisiae Infections in a Tertiary-Care Centre. [PDF]
Harmath A +7 more
europepmc +1 more source

